SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-012129
Filing Date
2024-04-16
Accepted
2024-04-15 21:52:27
Documents
6
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vtgn20240412_def14a.htm DEF 14A 706803
2 a01.jpg GRAPHIC 7653
3 capvsnl.jpg GRAPHIC 23609
4 capvstsr.jpg GRAPHIC 25531
5 proxy_page1.jpg GRAPHIC 254988
6 proxy_page2.jpg GRAPHIC 169087
  Complete submission text file 0001437749-24-012129.txt   1370581
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37761 | Film No.: 24846027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)